Kazuki Yatsuzuka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazuki Yatsuzuka has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Satoshi Yoshida
Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan
19 shared publications - Ken Shiraishi
Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan
14 shared publications - Yasuhiro Fujisawa
Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan
14 shared publications - Jun Muto
Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan
13 shared publications Jun Muto
From the Department of Dermatology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon city, Ehime Prefecture, Japan
12 shared publications- Masamoto Murakami
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
10 shared publications
Latest Publications
- 30 October 2026
- Published by Wolters Kluwer Health in Indian Journal of Dermatology
Cutaneous Graft-Versus-Host Disease-Like Reaction in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms: A Case Report
Was not provided for this article.
- 30 October 2026
- Published by Wolters Kluwer Health in Indian Journal of Dermatology
Cutaneous Graft-Versus-Host Disease-Like Reaction in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms: A Case Report
Was not provided for this article.
- 6 July 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (9) , e751-e753
Dyshidrotic Eczema Mimicking Palmoplantar Pustulosis During Apremilast Treatment: A Diagnostic Pitfall
- 6 July 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (9) , e751-e753
Dyshidrotic Eczema Mimicking Palmoplantar Pustulosis During Apremilast Treatment: A Diagnostic Pitfall
- 14 June 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
Successful Treatment of Bullous Pemphigoid Complicated by Possible Infective Endocarditis With Dupilumab Monotherapy: A Case Report
- 14 June 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
Successful Treatment of Bullous Pemphigoid Complicated by Possible Infective Endocarditis With Dupilumab Monotherapy: A Case Report
- Open Access
High-resolution spatial profiling identifies disease-specific molecular architecture in palmoplantar pustulosis
Palmoplantar pustulosis (PPP) and dyshidrotic eczema (DE) are chronic vesiculopustular dermatoses with overlapping clinical presentations but distinct underlying biology. Although comparative transcriptomic and proteomic analyses between PPP and DE have been reported, they remain limited in number and scope, with no comprehensive understanding of their distinct molecular signatures. Moreover, their molecular mechanisms remain unclear, and currently available therapeutic options are limited. To clarify disease-specific epidermal programs underlying vesicle formation, we conducted Visium HD spatial transcriptomic analysis of FFPE lesional skin samples obtained from patients with PPP and DE, followed by immunohistochemical validation against normal palmoplantar skin controls. Spatial clustering identified a keratinocyte subpopulation adjacent to vesicles that exhibited distinct transcriptional programs in the two diseases. In PPP, vesicle-associated keratinocytes demonstrated marked downregulation of aquaporin-3 (AQP3) and E-cadherin, together with strong, spatially localized activation of JAK-STAT3 signaling. Conversely, DE exhibited diffuse AQP3 expression and more homogeneous activation of JAK-STAT3 signaling throughout the epidermis. These results indicate that, although PPP and DE share inflammatory pathways, they differ substantially in their spatial molecular architecture. Reduced AQP3 expression and localized STAT3 activation may contribute to vesicle formation in PPP, supporting our previous hypothesis that implicates intraepidermal sweat leakage as a pathogenic mechanism in PPP. Abstract Figure:
Open AccessHigh-resolution spatial profiling identifies disease-specific molecular architecture in palmoplantar pustulosis
Palmoplantar pustulosis (PPP) and dyshidrotic eczema (DE) are chronic vesiculopustular dermatoses with overlapping clinical presentations but distinct underlying biology. Although comparative transcriptomic and proteomic analyses between PPP and DE have been reported, they remain limited in number and scope, with no comprehensive understanding of their distinct molecular signatures. Moreover, their molecular mechanisms remain unclear, and currently available therapeutic options are limited. To clarify disease-specific epidermal programs underlying vesicle formation, we conducted Visium HD spatial transcriptomic analysis of FFPE lesional skin samples obtained from patients with PPP and DE, followed by immunohistochemical validation against normal palmoplantar skin controls. Spatial clustering identified a keratinocyte subpopulation adjacent to vesicles that exhibited distinct transcriptional programs in the two diseases. In PPP, vesicle-associated keratinocytes demonstrated marked downregulation of aquaporin-3 (AQP3) and E-cadherin, together with strong, spatially localized activation of JAK-STAT3 signaling. Conversely, DE exhibited diffuse AQP3 expression and more homogeneous activation of JAK-STAT3 signaling throughout the epidermis. These results indicate that, although PPP and DE share inflammatory pathways, they differ substantially in their spatial molecular architecture. Reduced AQP3 expression and localized STAT3 activation may contribute to vesicle formation in PPP, supporting our previous hypothesis that implicates intraepidermal sweat leakage as a pathogenic mechanism in PPP. Abstract Figure:
- 19 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Anti–Laminin‐332 Subepidermal Autoimmune Blistering Disease With Extensive Cutaneous Involvement: A Case Report
- 19 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Anti–Laminin‐332 Subepidermal Autoimmune Blistering Disease With Extensive Cutaneous Involvement: A Case Report
- 7 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
A Case of IgM Pemphigoid Suggesting Possible Transition to IgG Mucous Membrane Pemphigoid
- 7 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
A Case of IgM Pemphigoid Suggesting Possible Transition to IgG Mucous Membrane Pemphigoid
- 6 February 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (4)
Severe Generalized Pustular Psoriasis With Systemic Capillary Leak Syndrome Successfully Treated With Spesolimab: A Case Report
- 6 February 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (4)
Severe Generalized Pustular Psoriasis With Systemic Capillary Leak Syndrome Successfully Treated With Spesolimab: A Case Report
- 6 January 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (3)
Scrotal Ulcer Caused by Pancreatic Juice Leakage Complicating Acute Pancreatitis: A Case Report
- 6 January 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (3)
Scrotal Ulcer Caused by Pancreatic Juice Leakage Complicating Acute Pancreatitis: A Case Report
- 28 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2) , 334-338
Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression
Ocular mucous membrane pemphigoid (MMP) presents a significant diagnostic challenge because of the typically low positivity rate of serum antibody. While direct immunofluorescence (DIF) of conjunctival biopsies yields a high positivity rate, its invasiveness limits routine application. To address this, we explored tear fluid—which contains detectable immunoglobulin G (IgG) and can be collected safely and minimally invasively—as an alternative sample source for immunological testing. This pilot study reports the first case of tear fluid–based indirect immunofluorescence (IIF) using oral mucosal tissue to evaluate disease activity in ocular MMP. A man in his 60s presented with ocular pain, conjunctival hyperemia, and erosions. He had a prior MMP diagnosis based on low‐titer serum anti‐BP180NC16a antibody, histopathology, DIF, and serum IIF. During the second exacerbation, serum anti‐BP180NC16a antibody was negative, and serum‐based IIF showed no linear deposition of IgG and C3. Tear fluid testing revealed linear IgG deposition along the basement membrane zone (BMZ) of oral mucosa, with titers of 1:20 (left eye) and 1:320 (right eye), correlating with clinical asymmetry. Control testing yielded negative results. Following remission, tear fluid–based IIF showed no IgG reactivity, indicating a correlation with disease activity. Notably, serum‐based IIF using oral mucosa was negative, while tear fluid–based IIF demonstrated clear IgG positivity, suggesting higher sensitivity in detecting ocular disease. In conclusion, tear fluid–based IIF using oral mucosa represents a novel and potentially more sensitive method for evaluating ocular MMP, warranting further validation.
- 28 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2) , 334-338
Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression
Ocular mucous membrane pemphigoid (MMP) presents a significant diagnostic challenge because of the typically low positivity rate of serum antibody. While direct immunofluorescence (DIF) of conjunctival biopsies yields a high positivity rate, its invasiveness limits routine application. To address this, we explored tear fluid—which contains detectable immunoglobulin G (IgG) and can be collected safely and minimally invasively—as an alternative sample source for immunological testing. This pilot study reports the first case of tear fluid–based indirect immunofluorescence (IIF) using oral mucosal tissue to evaluate disease activity in ocular MMP. A man in his 60s presented with ocular pain, conjunctival hyperemia, and erosions. He had a prior MMP diagnosis based on low‐titer serum anti‐BP180NC16a antibody, histopathology, DIF, and serum IIF. During the second exacerbation, serum anti‐BP180NC16a antibody was negative, and serum‐based IIF showed no linear deposition of IgG and C3. Tear fluid testing revealed linear IgG deposition along the basement membrane zone (BMZ) of oral mucosa, with titers of 1:20 (left eye) and 1:320 (right eye), correlating with clinical asymmetry. Control testing yielded negative results. Following remission, tear fluid–based IIF showed no IgG reactivity, indicating a correlation with disease activity. Notably, serum‐based IIF using oral mucosa was negative, while tear fluid–based IIF demonstrated clear IgG positivity, suggesting higher sensitivity in detecting ocular disease. In conclusion, tear fluid–based IIF using oral mucosa represents a novel and potentially more sensitive method for evaluating ocular MMP, warranting further validation.
- 27 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Successful Treatment of BRAF V600R ‐Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF / MEK Inhibitors
- 27 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Successful Treatment of BRAF V600R ‐Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF / MEK Inhibitors